BioNTech SE (BNTX) Enterprise Value (2018 - 2024)
BioNTech SE's Enterprise Value history spans 7 years, with the latest figure at -$7.5 billion for Q4 2024.
- For Q4 2024, Enterprise Value rose 57.86% year-over-year to -$7.5 billion; the TTM value through Dec 2023 reached -$17.8 billion, down 24.09%, while the annual FY2024 figure was -$7.6 billion, 57.55% up from the prior year.
- Enterprise Value for Q4 2024 was -$7.5 billion at BioNTech SE, up from -$17.8 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.6 billion in Q4 2020 and bottomed at -$17.8 billion in Q4 2023.
- The 5-year median for Enterprise Value is -$14.3 billion (2022), against an average of -$11.6 billion.
- The largest annual shift saw Enterprise Value plummeted 929.4% in 2021 before it soared 57.86% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$1.6 billion in 2020, then tumbled by 929.4% to -$16.5 billion in 2021, then increased by 13.23% to -$14.3 billion in 2022, then dropped by 24.09% to -$17.8 billion in 2023, then skyrocketed by 57.86% to -$7.5 billion in 2024.
- Per Business Quant, the three most recent readings for BNTX's Enterprise Value are -$7.5 billion (Q4 2024), -$17.8 billion (Q4 2023), and -$14.3 billion (Q4 2022).